Form 4 for MRNA Moderna
Accepted 2026-09-14 16:25:21 ET · period of report 2026-09-10 · accession 0001682852-26-000174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-14 16:25 | 2026-09-10 | MRNA | Mock James M | CFO | M - OptEx | $30.96 | +19.8K | 94.2K | +27% | +$614.1K |
| DMT | 2026-09-14 16:25 | 2026-09-10 | MRNA | Mock James M | CFO | S - Sale+OE | $134.49 | -34.8K | 59.4K | -37% | -$4.69M |
| DT | 2026-09-14 16:25 | 2026-09-10 | MRNA | Mock James M | CFO | M - OptEx | $0.00 | -19.8K | 43.6K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-10 | M | A | 19,836 | $30.96 | 94,211 | D | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026. |
| 2 | Common | Common Stock | 2026-09-10 | S | D | 19,836 | $134.49 | 74,375 | D | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026. |
| 3 | Common | Common Stock | 2026-09-10 | S | D | 15,000 | $134.49 | 59,375 | D | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-09-10 | M | D | 19,836 | $0.00 | 43,642 | D | $30.96 · — to 2035-03-01 | 19,836 Common Stock | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026. (F2) 25% of this option vested and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |